LAC 46:LIII.2713

LAC 46:LIII.2713. General Requirements

Last amended: 2026Year: 2026Length: 276 wordsOfficial source

Cite as La. Admin. Code tit. 46, pt. LIII, § 2713

A. Each CDS licensee shall comply with all applicable provisions of 21 CFR Parts 1300-1399. B. Records and Reports 1. All records required under 21 CFR Parts 1300-1399 shall be made available to the board, or its authorized agents, for inspection and copying upon request. 2. Reports submitted to the Automation of Reports and Consolidated Orders System (ARCOS) shall be provided to the board upon request. C. Theft or Significant Loss 1. A licensee shall notify the board in writing of any theft or significant loss of controlled substances, in accordance with 21 CFR Part 1301. D. Prescription Expiration 1. A prescription for a Schedule II controlled substance shall expire 90 days after the date it is issued. 2. A prescription for a Schedule III or IV controlled substance shall expire six months after the date it is issued or upon completion of the authorized refills specified by the prescriber, whichever occurs first. 3. A prescription for a Schedule V controlled substance shall expire one year after the date it is issued or upon completion of the authorized refills specified by the prescriber, whichever occurs first. E. Exception to Inventory Requirements of 21 CFR 1304.11 1. Pharmacies shall conduct an annual inventory of all controlled substances on hand. This inventory may be taken on any date, provided it is no later than 385 days after the previous inventory. 2. Pharmacies shall also conduct a new inventory under the following circumstances: a. upon the designation of a new pharmacist-in-charge; b. upon discovery of any theft or significant loss of controlled substances; c. upon the departure of a pharmacist-in-charge; and d. upon the permanent closure of the pharmacy.
LAC 46:LIII.2713: LAC 46:LIII.2713. General Requirements | Justis AI